The American Society of Plastic Surgeons (ASPS) is breaking rank with most U.S. medical associations over its stance on surgical procedures and hormone treatments for minors seeking gender transition. ASPS, with over 11,000 members across the United States and Canada, announced quietly in late July that it “has not endorsed any organization’s practice recommendations for the treatment of adolescents with gender dysphoria.”
ASPS’s decision effectively rejects the current consensus among medical trade associations—which many critics argue are captured by proponents of gender ideology. The trade group decision comes amidst member concerns regarding the lack of information on the long-term impact of gender transition surgeries and hormone replacement therapy. According to ASPS, there is “considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions.”
Additionally, the group states that “existing evidence base is viewed as low quality/low certainty.” The move comes amidst the release of the state-sponsored Cass Review in Britain, which contends the current medical consensus on gender dysphoria and minors is not based on scientific and medical expertise but on the opinions of non-governmental organizations like the World Professional Association for Transgender Health (WPATH) which pushes gender ideology as part of its mission.
Following the Cass Review and several medical studies, numerous countries in Europe abruptly ended gender transition procedures for children. W
There is growing evidence that the procedures do not produce the mental or physical health outcomes purported by those who push gender ideology, and growing concern in the medical community about the long-term risk o malpractice suits.
The legal impacts of transition procedures—especially if additional research suggests little to no medical positives—could see additional associations join the ASPS.
show less
